Trials / Sponsors / Angimmune LLC
Angimmune LLC
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Stage IV Melanoma | Phase 1 / Phase 2 | 2017-01-01 |
| Unknown | Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides Mycosis Fungoides | Phase 2 | 2017-01-01 |
| Terminated | A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanom Melanoma | Phase 1 / Phase 2 | 2014-02-01 |
| Completed | A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) T-cell Lymphomas, T-cell Leukemia, Sezary Syndrome | Phase 2 | 2008-01-01 |